Sandoz announces agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics
  • Sandoz to acquire three established brands sold in more than 100 markets
  • Acquisition, including leading global brand Zinnat®, confirms Sandoz commitment to antibiotics, following plans to expand its integrated manufacturing site in Kundl
  • Transaction complements Sandoz leadership in generic penicillins with a leading position in cephalosporins – largest antibiotic segment by global sales

Basel, February 11, 2021 – Sandoz, a Novartis division, has signed an agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading …

/by
Novartis delivered sales growth and margin expansion. Continued to progress its next wave of medicines in 2020.
  • Full year net sales from continuing operations¹ up 3% (cc², +3% USD):
    • Pharmaceuticals BU grew 5% (cc) driven by Entresto (+44% cc), Zolgensma (reaching USD 0.9 billion), Cosentyx (+13% cc), Ilaris (+31% cc) and the Xiidra acquisition (+95% cc)
    • Oncology BU grew 3% (cc) driven by Promacta/Revolade (+23% cc), Jakavi (+20% cc), Kisqali (+45% cc), Tafinlar + Mekinist (+16% cc) and Piqray (reaching USD 0.3 billion)
    • Sandoz sales …
/by
Sandoz officially certified as Global Top Employer 2021
  • Top Employers Institute recognizes Sandoz for its exceptional employee offerings globally
  • Third such annual certification for Sandoz underlines ongoing commitment to attract and keep best talent by building a great place to work

Basel, January 25, 2021 – Sandoz, a Novartis division, is pleased to announce that it has been officially awarded “Global Top Employer 2021” certification for the third year in a row. This year, Sandoz was one of only 16 Top Employers recognized for their outstanding HR …

/by
Sandoz appoints new Board representative to global AMR Industry Alliance
  • Dominic De Souza, global head of Anti-Infectives sustainability and AMR program, appointed to represent Sandoz on AMR Industry Alliance
  • Alliance brings together approximately 100 life science companies / associations in search of sustainable solutions to curb antimicrobial resistance (AMR)
  • Sandoz, as largest global provider of generic antibiotics, is committed to driving a pragmatic and balanced approach to tackling this growing global health threat

Holzkirchen, October 20, 2020 — Sandoz is pleased to announce the …

/by
Sandoz Donates 20 critically needed generic medicines to hospitals and dispensaries in continued support of the people of Beirut

In continued support of the people of Beirut, Lebanon impacted by the August 4 port explosion and the ongoing rebuilding efforts, Sandoz has donated 20 critically needed generic medicines through the non-governmental organization (NGO), Beit el Baraka.

The donations will be disbursed to severely damaged hospitals and also dispensaries in order to best respond to the ongoing devastation, and supports the initial monetary donation from Novartis to the Red Cross for early relief efforts.

Sandoz is thankful for the safety of our associates who live and work in Lebanon, and grateful …

/by
Sandoz launches its first RFID-tagged critical injectable medicines with Kit Check to optimize supply chain and automate restocking in US hospitals
  • First three Sandoz medicines labeled with RFID technology will be available in US hospitals starting in October, followed by several more through Q1 2021
  • Sandoz and Kit Check together provide comprehensive solutions to hospital customers to lower costs, reduce risks and treat patients safely and more efficiently
  • Advanced tracking technology streamlines inventory, workflow and auditing processes, further advancing Sandoz goal of being supplier of choice in hospitals

…

/by
Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe
  • Sandoz and Austrian government announce joint plans to drive long-term competitiveness of European production for key antibiotics in Europe
  • Planned combined investment of more than EUR 150 million would include major innovative technology development and implementation for large-scale manufacture of active ingredients for leading penicillin products
  • Kundl manufacturing site in Austria is hub of last vertically integrated antibiotics production chain in Europe; Sandoz is #1 global supplier of generic antibiotics

Holzkirchen, July 27 …

/by
Sandoz launches generic antibiotic Daptomycin in US, strategically growing injectables portfolio and strengthening hospital offering
  • Daptomycin is an antibacterial medicine used to treat adult patients with complicated skin and skin structure infections 1
  • Daptomycin can be used to treat patients with MRSA or “superbug” infections2
  • Introduction of Daptomycin further enhances Sandoz industry-leading antibiotic portfolio, which covers 50 percent of antibiotics available worldwide

Princeton, New Jersey, July 13, 2020 — Sandoz Inc. today announced the US market introduction of Daptomycin for …

/by
Sandoz collaborates with Civica Rx to help reduce critical generic medicine shortages in US hospitals
  • Sandoz to provide six injectable medicines used in acute care settings to help ensure supply reliability for optimal patient care
  • Securing reliable supply of and access to these high-quality medicines will help ensure fewer shortages and interruptions for patients requiring critical medicines
  • As a worldwide leader in generic and biosimilar medicines, Sandoz is committed to supporting efforts to deliver vital generic medicines to patients

Princeton, New Jersey, July 7, 2020 — Sandoz Inc. today announced it has …

/by
Sandoz reviewing options after Federal Circuit upholds lower court ruling in biosimilar Erelzi® case
  • Sandoz evaluating next steps, including potential appeal to US Supreme Court
  • Ruling continues to prevent launch of important, affordable treatment option for US patients affected by chronic autoimmune and inflammatory diseases
  • Sandoz remains deeply committed to making Erelzi available to US patients as soon as possible, contributing to a more sustainable healthcare system

Holzkirchen, Germany, July 1, 2020 – Sandoz, a Novartis division and a global leader in biosimilars, today announced that the US Court of …

/by